Altaris Capital Partners acquires 3M Drug Delivery Systems, launches Kindeva

Altaris Capital Partners has acquired 3M Drug Delivery Systems in a $650 million transaction, launching it as an independent company named Kindeva Drug Delivery, with 3M retaining a 17% minority interest.

“Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, today announced its launch as an independent company following the acquisition by Altaris Capital Partners in a transaction valued at $650 million.”biospace.com

• 2 sources
• biospace.comKindeva Drug Delivery, Formerly 3M Drug Delivery Systems, Launches as an Independent Company - BioSpaceAngela GabrielMay 1, 2020
• biopharminternational.comFormer 3M Drug Delivery Systems Launches as Kindeva Drug DeliveryMay 4, 2020

Summarized from public sources; check the original articles before acting on it.